Who Generates More Revenue? Amgen Inc. or argenx SE

Revenue Showdown: Amgen Inc. vs. argenx SE

In the competitive landscape of biotechnology, revenue generation is a key indicator of success. Over the past decade, Amgen Inc. has consistently outperformed argenx SE in terms of revenue. From 2014 to 2023, Amgen's revenue grew by approximately 40%, reaching a peak of $28.19 billion in 2023. In contrast, argenx SE, a rising star in the biotech sector, saw its revenue increase dramatically by over 26,000% during the same period, albeit from a much smaller base, reaching $1.23 billion in 2023.

This stark contrast highlights the different stages of growth for these companies. While Amgen remains a giant with steady growth, argenx SE's rapid revenue increase reflects its aggressive expansion and innovation strategy. As the biotech industry evolves, these revenue trends offer a glimpse into the future dynamics of market leadership.